Non-invasive Diagnosis of Pleural Malignancies: The Role of Tumor Markers
Source: PubMed.com
Serum markers are an attempt to diagnose mesothelioma malignancies by analysis of a blood or other fluid test. This is a non-invasive procedure and discovering the efficacy of these diagnostic materials will be an important progression in our ability to diagnose mesothelioma. A study was recently completed that looked at the use of three different markers and their efficacy of diagnosis. It was found that Cyfra 21.1 was able to discriminate between healthy and malignant cells and that the combination of soluble mesothelin-related protein (SMRP) and carcino-embrionic antigen (CEA) was very effective for distinguishing between mesothelioma and non-small cell lung cancer.
Serum markers are an attempt to diagnose mesothelioma malignancies by analysis of a blood or other fluid test. This is a non-invasive procedure and discovering the efficacy of these diagnostic materials will be an important progression in our ability to diagnose mesothelioma. A study was recently completed that looked at the use of three different markers and their efficacy of diagnosis. It was found that Cyfra 21.1 was able to discriminate between healthy and malignant cells and that the combination of soluble mesothelin-related protein (SMRP) and carcino-embrionic antigen (CEA) was very effective for distinguishing between mesothelioma and non-small cell lung cancer.
Labels: mesothelioma
posted by Belluck & Fox at
1:57 PM
© Belluck & Fox, L.L.P. All rights reserved.
